Biotech, Cannabis, Food & Drug, & Pharma Law Updates

HB Ad Slot
HB Mobile Ad Slot

In today’s hyper-aware environment, concerns about food and drug safety are paramount for both companies and consumers.  The Food and Drug Administration (FDA) and the US Department of Agriculture (USDA) regulates the areas of biotech, food, and drug law. Additionally, laws including the 21st Century Cures Act, and cGMP (Current Good Manufacturing Processes), regulate industry standards/norms in food, cosmetics, and other industry-sectors. Visitors to the National Law Review will find the latest analysis of news, legislation, and upcoming cases/litigation as it relates to this area of law.

With researchers searching for new energy solutions and other developments in biotech, visitors to the NLR will have the opportunity to read content surrounding biosimilars, natural fuel production, medical devices, biotechnology, nanotechnology and materials, and the pharmaceuticals industry. Additionally, content relating to food and drug laws, limits on chemical use in cosmetic products, and other general health/safety topics are covered by the National Law Review and are updated regularly. Additionally, food safety and imports to the United States are also discussed as they become relevant. 

In addition to general health, science, and food/drug, the industry is also closely related to many of the issues related to intellectual property law. New applications for patents, intellectual property, licensing laws, and other areas which are governed by the PTAB court, often crossover into the industry.

New developments in legislation, including the legalization of recreational marijuana has created a new area ripe for legal analysis.  Regulations on how recreational marijuana can be advertised and marketed, distributed and the kind of insurance coverage necessary for dispensaries.  Additionally, employer drug-testing and marijuana statutes have been a hot area of litigation covered by the National Law Review.  

General practices in marketing standards, compliance of federal and state laws/legislation, licensing collaborations, and news related to bringing new products to the market, in the US and abroad, are among the areas visitors to NLR will read about daily. Drug pricing, changes in production standards, regulatory compliance, food safety and handling, drug laws (legalization of marijuana, both recreational and medicinal in the workplace), and labeling and nutritional requirements, are among the many topics covered by the National Law Review daily.

Visitors will always find the latest, up-to-date, most comprehensive coverage on the site. And, news and stories which affect the US, companies which are regulated in the industry, and multinational/international companies, are detailed regularly for NLR readers.

National Law Review Cannabis TwitterFor hourly updates on the latest news about biotech, food & drug, and cannabis laws, regulations, and legislation, be sure to follow our Cannabis X (formerly Twitter) feed, and sign up for complimentary e-news bulletins.

Recent Biotech, Cannabis, Food & Drug, & Pharma Administration News

Title
Publication Date Organization
Jul
2
2020
High Risk of Second Requests in the Cannabis Industry Sheppard, Mullin, Richter & Hampton LLP
Jul
2
2020
Chinese Food Industry Proposes the First Group Standard for Plant-Based Meat Keller and Heckman LLP
Jul
1
2020
FinCEN Issues Guidance to Financial Institutions on Hemp-Related Due Diligence Greenberg Traurig, LLP
Jul
1
2020
EC Amends REACH Annex II to Include SDS Requirements for Nanoforms Bergeson & Campbell, P.C.
Jul
1
2020
Healthcare Industry Antitrust Measures Advance as Pandemic Pressures Persist MoginRubin
Jul
1
2020
West Virginia Commences Regulating Entire CBD Industry Steptoe & Johnson PLLC
Jul
1
2020
USDA and FDA Issue Joint Statement on Food Export Restrictions Related to COVID-19 Keller and Heckman LLP
Jul
1
2020
EFSA Prioritizes Substances without an SML for Re-evaluation Keller and Heckman LLP
Jul
1
2020
Class of End-Payors Certified in Illegal Monopolization Suit Against Drug Maker Allergan MoginRubin
Jul
1
2020
Federal Judge Denies Plant-Based “Butter” Motion to Dismiss Keller and Heckman LLP
Jun
30
2020
Compensation Considerations for Emerging Biotech and Life Sciences Companies Jones Walker LLP
Jun
30
2020
Ninth Circuit’s Ingredients List Rule Keeps Nestlé in Hot Water with Denial of Nestlé’s Statute of Limitations-Based Summary Judgment Motion Faegre Drinker
Jun
30
2020
Cosmetics Sold in California are Set for a Face Lift Hunton Andrews Kurth
Jun
30
2020
Insurers Have Duty to Defend Opioid Cases According to Ohio Appellate Court Hunton Andrews Kurth
Jun
30
2020
CDC and OSHA Issue Guidance for Sea Food Processors During the COVID-19 Pandemic Keller and Heckman LLP
Jun
30
2020
Ohio Appellate Court Rules That Insurer Must Defend Party Involved In Opioid MDL Barnes & Thornburg LLP
Jun
30
2020
Federal Circuit Focuses On Active Ingredient, Not Active Moiety, For Scope Of Patent Term Extension Foley & Lardner LLP
Jun
29
2020
A Budding Challenge for Employers? Louisiana Expands Access to Medical Marijuana Ogletree, Deakins, Nash, Smoak & Stewart, P.C.
Jun
29
2020
Vermont’s Plastic Bag Ban Takes Effect July 1; Other States Push Back on Bans Keller and Heckman LLP
Jun
29
2020
Pennsylvania Governor Issues Additional Updated Guidance for Hospitality Businesses Conducting In-Person Service (Second Update) Norris McLaughlin P.A.
Jun
29
2020
Current Good Manufacturing Practices in the Time of COVID-19: FDA Announces New Expectations on Risk Assessment and Risk Management Epstein Becker & Green, P.C.
Jun
27
2020
Non-Alcoholic Beer Regulation 101 McDermott Will & Emery
Jun
26
2020
NIOSH Publishes Program Performance One-Pager for Nanotechnology Research Center Bergeson & Campbell, P.C.
Jun
26
2020
Court Bars CA Prop 65 Glyphosate Warning Requirement Keller and Heckman LLP
Jun
26
2020
Its High Time: Will Somebody Please Tell the Cannabis Industry about the TCPA Already? Troutman Amin, LLP
Jun
26
2020
California Federal Judge Enters Permanent Injunction Barring Enforcement of Prop. 65 Cancer Warning for Glyphosate as Unconstitutional Compelled Speech Keller and Heckman LLP
Jun
26
2020
CMS Proposes Rule to Pave the Way for Value-Based Drug Purchasing Mintz
Jun
26
2020
Market Entry and Real World Data – China’s Medical Device Industry K&L Gates
 

NLR Logo

We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up to receive our free e-Newsbulletins

 

Sign Up for e-NewsBulletins